Answers are grounded in this paper and cite their sources.
Diabetic patients exhibit increased release of platelet factor 4 during platelet aggregation, which may contribute to the pathogenesis of thromboembolic complications.
Summary The release of platelet factor 4 during platelet aggregation was investigated in diabetic patients. We observed an increased release of platelet factor 4 in diabetic patients. The authors suggest that the increased release of platelet factor 4 may play an essential role in pathogenesis of thromboembolic complications in diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Chmielewski et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: